Jessica Rago
Dallas, Texas, 75247, United States
NCT Number: NCT04637321
2.1. Study Objectives
* Primary Objective(s) * Identify the incidence and risk of CDI within one year after kidney, liver, and/or pancreas transplant * Secondary Objective(s) * Identify the risk factors for recurrent CDI post-transplant in patients who were diagnosed with a CDI within one year prior to Solid Organ Transplant * Evaluate the impact of CDI on graft survival following Solid Organ Transplant
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Dallas, Texas, 75247, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Data will be collected on all liver, kidney, pancreas and combined transplant recipients who received their graft(s) from April 1, 2015 to July 31, 2018
Time frame: April 1, 2014 to July 31, 2019
Incidence of C. Difficile infection within one year post-transplant for CDI post-transplant.
Time frame: April 1, 2014 to July 31, 2019
Risk factors transplanted organ
Time frame: April 1, 2014 to July 31, 2019
Origin of transplanted graft including age of donor
Time frame: April 1, 2014 to July 31, 2019
Induction agent used
Time frame: April 1, 2014 to July 31, 2019
Acid suppression
Time frame: April 1, 2014 to July 31, 2019
First time SOT recipient
Time frame: April 1, 2014 to July 31, 2019
History of CDI in the year prior to transplant
Time frame: April 1, 2014 to July 31, 2019
Co-infection with HIV/AIDS
Time frame: April 1, 2014 to July 31, 2019
Length of hospital stay
Time frame: April 1, 2014 to July 31, 2019
Length of intensive care unit stay
Time frame: April 1, 2014 to July 31, 2019
Intra-operative administration of blood products
Time frame: April 1, 2014 to July 31, 2019
Antibiotic use in the 90 days prior to infection
Time frame: April 1, 2014 to July 31, 2019
Antibiotic use in the 90 days post-transplant
Time frame: April 1, 2014 to July 31, 2019
Hospitalization in the 90 days prior to transplantation
Time frame: April 1, 2014 to July 31, 2019
Hospitalization in the 90 days post-transplant
Methodist Health System
Other
Everyone Poops: An Evaluation of the Incidence and Risk Factors for Clostridioides Difficle Infection in Solid Organ Transplant Recipients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02382211
Infection in Solid Organ Transplant Recipients
Tucson, Arizona, United States
View Trial DetailsNCT02503982
Infection in Solid Organ Transplant Recipients
Petah Tikva, Israel
View Trial DetailsNCT02260596
Complications of Organ Transplant, Infection in Solid Organ Transplant Recipients
Durham, North Carolina, United States
View Trial DetailsNCT01761435
Infection in Solid Organ Transplant Recipients, Infections
Barcelona, Spain
View Trial Details